4C Mortality Score and high-flow nasal oxygen therapy outcome in COVID-19
P. Pobeha (Košice, Slovakia), I. Paranicova (Košice, Slovakia), S. Bodnarova (Košice, Slovakia), P. Skyba (Košice, Slovakia), P. Jonek (Košice, Slovakia), E. Sokolova (Košice, Slovakia), I. Libakova (Košice, Slovakia), P. Joppa (Košice, Slovakia)
Source: International Congress 2022 – Severe COVID-19: clinical data
Session: Severe COVID-19: clinical data
Session type: Thematic Poster
Number: 550
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Pobeha (Košice, Slovakia), I. Paranicova (Košice, Slovakia), S. Bodnarova (Košice, Slovakia), P. Skyba (Košice, Slovakia), P. Jonek (Košice, Slovakia), E. Sokolova (Košice, Slovakia), I. Libakova (Košice, Slovakia), P. Joppa (Košice, Slovakia). 4C Mortality Score and high-flow nasal oxygen therapy outcome in COVID-19. 550
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|